{"id":38144,"date":"2022-09-27T14:48:40","date_gmt":"2022-09-27T13:48:40","guid":{"rendered":"https:\/\/www.he-arc.ch\/?post_type=he-arc_project&p=38144"},"modified":"2023-01-04T14:25:55","modified_gmt":"2023-01-04T13:25:55","slug":"avalglyc-io","status":"publish","type":"he-arc_project","link":"https:\/\/www.he-arc.ch\/en\/projets-recherche\/avalglyc-io\/","title":{"rendered":"AvalGlyc.io"},"content":{"rendered":"\n
Biosensors are increasingly being developed to provide clinicians with rapid quantitative diagnostic information to guide patients\u2019 treatments without the need of a centralized laboratory testing. They can also be used in low-resource settings, without highly trained medical staff, thus having the potential to greatly improve patients\u2019 care especially regarding disease management where complex sample handling is undesirable. <\/p>\n\n\n\n
Blood glucose monitoring is a key example where technological innovation has responded to a multi-level clinical needs, from the pathology laboratory to the patient’s home. However, despite the recent progress, these methods still remain invasive and uncomfortable for the patients for daily use. <\/p>\n\n\n\n
Our approach will be a product of type point-of care and low cost with an objective to be a complementary solution to the existing invasive methods in order to reduce the number of the invasive glucose measurements.<\/p>\n\n\n\n
This project\u2019s goal is to conceive and implement a non-invasive glucose monitoring system, in the form of a point-of-care system able to predict an increased risk of abnormal glycemia thus allowing patients with Type I diabetes to manage their disease in a simple and comfortable way.<\/p>\n\n\n\n
HES-SO Valais<\/a> <\/p>\n\n\n\n